Screener
Surgery Partners, Inc. SGRY Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Surgery Partners, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Surgery Partners, Inc.’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001638833-26-000077
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Depreciation and amortization | 77.8 | 76.6 |
| Non-cash lease expense | 20.3 | 19.5 |
| Non-cash interest expense, net | 4.5 | 4.0 |
| Equity-based compensation expense | 9.6 | 14.4 |
| Net loss on disposals, consolidations and deconsolidations | 6.7 | 3.4 |
| Deferred income taxes | 0.9 | (1.8) |
| Equity in earnings of unconsolidated affiliates, net of distributions received | 1.4 | 0.2 |
| Changes in operating assets and liabilities, net of acquisitions and divestitures: |
Item 1. Financial Statements
FAQ
- What is Surgery Partners, Inc.'s stock-based comp?
- Surgery Partners, Inc. (SGRY) reported stock-based comp of $3.8M in Q2 2026.
- How has Surgery Partners, Inc.'s stock-based comp changed year-over-year?
- Surgery Partners, Inc.'s stock-based comp decreased by 44.1% year-over-year, from $6.8M to $3.8M.
- What is the long-term trend for Surgery Partners, Inc.'s stock-based comp?
- Over 3 years (2021 to 2024), Surgery Partners, Inc.'s stock-based comp has grown at a 24.2% compound annual growth rate (CAGR), from $17.4M to $33.3M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Surgery Partners, Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude